Canaccord Genuity Upgrades Merit Medical Systems to Buy, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young has upgraded Merit Medical Systems (NASDAQ:MMSI) from Hold to Buy and increased the price target from $76 to $100.
December 21, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems was upgraded by Canaccord Genuity from Hold to Buy with a raised price target from $76 to $100, indicating a positive outlook on the stock.
Upgrades by analysts, especially with a significant increase in price target, tend to have a positive impact on the stock price in the short term as they reflect a positive change in the company's outlook and can influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100